>> GNI, Ltd. 

         GNI, Ltd. (www.gnipharma.com) is an international pharmaceutical development company with campuses in Tokyo and Fukuoka, Japan, and Cambridge, U.K.  Its primary focus is on the discovery and development of drugs that treat inflammation and cancer.  Using gene regulatory networks and systems pharmacology techniques, GNI develops its therapeutics both in-house and in collaboration with other pharmaceutical companies.  Its proprietary techniques, based on the pioneering research being done by its scientific founders at the University of Cambridge (Cambridge, UK), Kyushu University and University of Tokyo in Japan, enable GNI to identify for each disease studied the key “causal” druggable genes and thus, to improve development productivity significantly.